PIA
ZOM

Piedmont Investment Advisors’s Zomedica Corp. ZOM Stock Holding History

Piedmont Investment Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-685
Closed -$2K – 2711
2018
Q2 		$2K Buy
+685
New +$1.38K ﹤0.01% 2688

Other funds holding ZOM

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Piedmont Investment Advisors's ZOM Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Zomedica Corp. (ZOM) in Q3 2018, closing a stake of 685 shares — an estimated $2K sold.

Piedmont Investment Advisors first reported a position in ZOM in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 35 funds tracked by Wall St. Rank hold ZOM as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Zomedica Corp. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 685 Zomedica Corp. shares in Q3 2018, an estimated $2K.
  • Piedmont Investment Advisors first reported a position in Zomedica Corp. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Zomedica Corp. position peaked at $2K in Q2 2018.
  • 35 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.